Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00021307 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study not activated.

Conditions

Interventions

Sponsor

Fox Chase Cancer Center

Collaborators